Clinical trials in children with Down syndrome: issues from a cognitive research perspective.

Published

Journal Article (Review)

Clinical and translational research play a key role in the transition of basic research discoveries to effective therapies. In Down syndrome (DS), these research approaches are not well utilized or developed to test new therapies to improve cognitive and/or adaptive function in this population. This article reviews the history of clinical trial research in children with DS from a cognitive research perspective and discusses important issues relevant to the conduct of well designed clinical trials for this population. Specific issues addressed include: funding, study design, study medication, subject recruitment and retention, safety, and efficacy challenges. The Duke Down Syndrome Research Team's program of clinical research of cholinesterase inhibitors for individuals with DS serves as the model application for the identified research principles. It is hoped that this article will raise awareness of the unmet need for clinical research in the cognitive and adaptive function of individuals with DS, especially children with DS.

Full Text

Duke Authors

Cited Authors

  • Heller, JH; Spiridigliozzi, GA; Crissman, BG; Sullivan-Saarela, JA; Li, JS; Kishnani, PS

Published Date

  • August 15, 2006

Published In

Volume / Issue

  • 142C / 3

Start / End Page

  • 187 - 195

PubMed ID

  • 16838317

Pubmed Central ID

  • 16838317

International Standard Serial Number (ISSN)

  • 1552-4868

Digital Object Identifier (DOI)

  • 10.1002/ajmg.c.30103

Language

  • eng

Conference Location

  • United States